Jingle Xi

424 total citations
10 papers, 341 citations indexed

About

Jingle Xi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jingle Xi has authored 10 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Jingle Xi's work include RNA Interference and Gene Delivery (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Jingle Xi is often cited by papers focused on RNA Interference and Gene Delivery (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Jingle Xi collaborates with scholars based in China and United States. Jingle Xi's co-authors include Jing An, Jessica Lo, Chinaza Egbuta, Daniel Morton, Damien Valette, Susan Hubbell, Huw M. L. Davies, Wenhua Jiang, Jennifer Griswold and Debashis Ghosh and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Materials Science and Engineering C.

In The Last Decade

Jingle Xi

9 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jingle Xi China	7	145	94	81	73	60	10	341
Matti Lepistö Sweden	11	201 1.4×	74 0.8×	99 1.2×	42 0.6×	44 0.7×	16	378
Olga E. Andreeva Russia	14	231 1.6×	141 1.5×	119 1.5×	66 0.9×	28 0.5×	40	406
Laura Caboni Ireland	9	289 2.0×	87 0.9×	76 0.9×	74 1.0×	30 0.5×	11	441
Achille Panzeri Italy	11	121 0.8×	89 0.9×	79 1.0×	36 0.5×	16 0.3×	18	327
Jean-Pierre Hénichart France	11	268 1.8×	40 0.4×	99 1.2×	122 1.7×	29 0.5×	18	428
Marla Simmons-Menchaca United States	8	227 1.6×	58 0.6×	74 0.9×	53 0.7×	19 0.3×	8	368
Anna I. Koutsourea Greece	13	198 1.4×	54 0.6×	226 2.8×	66 0.9×	33 0.6×	22	377
Ronald Grigg United Kingdom	10	255 1.8×	121 1.3×	121 1.5×	108 1.5×	14 0.2×	11	512
Vishal Chandra India	10	126 0.9×	63 0.7×	75 0.9×	54 0.7×	8 0.1×	17	402
Zhiye Hu China	15	280 1.9×	114 1.2×	187 2.3×	105 1.4×	34 0.6×	20	463

Countries citing papers authored by Jingle Xi

Since Specialization

Citations

This map shows the geographic impact of Jingle Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingle Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingle Xi more than expected).

Fields of papers citing papers by Jingle Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingle Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingle Xi. The network helps show where Jingle Xi may publish in the future.

Co-authorship network of co-authors of Jingle Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Jingle Xi. A scholar is included among the top collaborators of Jingle Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingle Xi. Jingle Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Sun, Huiying, Hao Lu, Jiani Wu, et al.. (2025). Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy. BMC Cancer. 25(1). 697–697. 3 indexed citations

Qiu, Miao‐Zhen, Yang Zhang, Ye Guo, et al.. (2022). Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors. JAMA Oncology. 8(7). 1042–1042. 42 indexed citations

Wu, Duoguang, Wenjian Wang, Xiaotian He, et al.. (2018). Biofabrication of nano copper oxide and its aptamer bioconjugate for delivery of mRNA 29b to lung cancer cells. Materials Science and Engineering C. 97. 827–832. 17 indexed citations

Xi, Jingle, et al.. (2018). Suppression of GRP78 sensitizes human colorectal cancer cells to oxaliplatin by downregulation of CD24. Oncology Letters. 19 indexed citations

Wang, Wenjian, et al.. (2017). WITHDRAWN: Biofabrication of nano copper oxide and its aptamer bioconjugate for delivery of mRNA 29b to lung cancer cells. Materials Science and Engineering C.

Cui, Fei, Duoguang Wu, Xiaotian He, et al.. (2016). Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition. Tumor Biology. 37(8). 10871–10876. 34 indexed citations

Han, Xiaofeng, Yan Xu, Yilei Yang, et al.. (2013). Discovery and Characterization of a Novel Cyclic Peptide That Effectively Inhibits Ephrin Binding to the EphA4 Receptor and Displays Anti-Angiogenesis Activity. PLoS ONE. 8(11). e80183–e80183. 13 indexed citations

Xi, Jingle, Yongmei Feng, Na Huang, et al.. (2013). Development of a Novel Class of Tubulin Inhibitors with Promising Anticancer Activities. Molecular Cancer Research. 11(8). 856–864. 37 indexed citations

Ghosh, Debashis, Jessica Lo, Daniel Morton, et al.. (2012). Novel Aromatase Inhibitors by Structure-Guided Design. Journal of Medicinal Chemistry. 55(19). 8464–8476. 174 indexed citations

10.

Zheng, Dayong, et al.. (2007). [Avastin combined with cisplan inhibits malignant ascites production in nude mice bearing transplanted ovary carcinoma with high VEGF expression].. PubMed. 27(5). 647–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact